InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,329.65
(
-2.15%
)
US TECH 100
17,920.80
(
-2.53%
)
Dow Jones
39,523.72
(
-2.04%
)
Brent Oil
76.84
(
-3.91%
)
Bitcoin
63,238.29
(
-3.23%
)
Post# of 252776
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 834
Posts 120193
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 107272

Tuesday, 10/26/2010 7:59:05 PM

Tuesday, October 26, 2010 7:59:05 PM

Post# of 252776
Quiz answer:

I think that the…response-guided therapy in this study is based on negative HCV RNA at week 4 only.

Correct! In prior HCV trials that incorporated response-guided therapy, a patient had to have undetectable virus at week 4 and a later measurement (usually at week 10 or week 12) in order to qualify for a 24-week (rather than a 48-week) regimen.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up